Issues pertaining to funding levels for the National Institutes of Health, the National Science Foundation, the Department of Health and Human Services, the Department of Defense.
Issues related to Congressionally Directed Spending.
Issues related to biomedical research.
Issues related to biomedical research.
Animal model use in biomedical research.
Issues related to the Animal Welfare Act.
Farm Bill reauthorization.
Issues related to animal model use in biomedical research.
National Defense Authorization Act
Duration: October 2, 2017
to
present
General Issues: Budget/Appropriations , Health Issues , Medical/Disease Research/Clinical Labs , Agriculture , Animals , Defense , Transportation , Immigration
Spending: about $800,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Office of Science & Technology Policy (OSTP), Defense - Dept of (DOD), Transportation - Dept of (DOT)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
JILL HOMER STEWART Legislative Director - Representative Peter J. Viclosky
Staff Assistant - Representative Robert A. Weygand
Staff Assistant - Senator Dianne Feinstein
Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein
Jill Homer Stewart The Ja Legislative Director - Representative Peter J. Viclosky Staff Assistant -Representative Robert A. Weygand Staff Assistant - Senator Dianne Feinstein
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 16.
Original Filing: 301525215.xml
Lobbying Issues
Issues pertaining to funding levels for the National Institutes of Health, the National Science Foundation, the Department of Health and Human Services, the Department of Defense.
Issues related to Congressionally Directed Spending.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act.
Farm Bill reauthorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 16, 2023.
Original Filing: 301501435.xml
Lobbying Issues
Issues pertaining to funding levels for the National Institutes of Health, the National Science Foundation, the Department of Health and Human Services, the Department of Defense.
Issues related to Congressionally Directed Spending.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act.
Farm Bill reauthorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 18, 2023.
Original Filing: 301479923.xml
Lobbying Issues
Issues pertaining to funding levels for the National Institutes of Health, the National Science Foundation, the Department of Health and Human Services, the Department of Defense.
Issues related to Congressionally Directed Spending.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act.
Farm Bill reauthorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301456914.xml
Lobbying Issues
Issues pertaining to funding levels for the National Institutes of Health, the National Science Foundation, the Department of Health and Human Services, the Department of Defense.
Issues related to Congressionally Directed Spending.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research.
Animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act.
Farm Bill reauthorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal model use in biomedical research.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301438366.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
H.R. 7152/S. 3534, the Tracking Pathogens Act
the Advanced Research Projects Agency for Health (ARPA-H)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Issues related to the FDA user fee programs and FDA Modernization Act (H.R. 7667, S. 4348)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Issues related to the FDA user fee programs and FDA Modernization Act (H.R. 7667, S. 4348)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Safety of pedestrians and cyclists in rural areas.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301413074.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
H.R. 7152/S. 3534, the Tracking Pathogens Act
the Advanced Research Projects Agency for Health (ARPA-H)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Issues related to the FDA user fee programs (H.R. 7667, S. 4348)
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Issues related to the FDA user fee programs (H.R. 7667, S. 4348)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Safety of pedestrians and cyclists in rural areas.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 18, 2022.
Original Filing: 301382431.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
H.R. 7152/S. 3534, the Tracking Pathogens Act
the Advanced Research Projects Agency for Health (ARPA-H)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Safety of pedestrians and cyclists in rural areas.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301365675.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
H.R. 7152/S. 3534, the Tracking Pathogens Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Safety of pedestrians and cyclists in rural areas.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301331288.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301304402.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Issues related to the creation of a proposed Advanced Research Project Agency-Health agency.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal models and animals use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Supply chain issues caused by transportation infrastructure.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 15, 2021.
Original Filing: 301276681.xml
Lobbying Issues
Issues related to NIH and NSF funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301263045.xml
Lobbying Issues
Issues related to NIH funding, including annual appropriations bills.
Issues related to community sponsored funding requests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures.
S.236/H.R. 791, the Tracking COVID 19 Variants Act
Issues related to genomic surveillance and sequencing
H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to biomedical research, and animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Animal Welfare Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Rural transportation issues including car pooling incentives and rural buses.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to visas for foreign national employees.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 15, 2021.
Original Filing: 301231681.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including annual appropriations for the National Institutes of Health and the National Science Foundation.
COVID related relief packages. including:
- HR 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
- HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act
Funding issues pertaining to commuter transportation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
Issues pertaining to COVID-19, including testing and animal model development.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations.
Issues pertaining to COVID-19 diagnosis and animal model discovery.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Issues pertaining to the transportation and shipment of laboratory animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in biomedical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to recruiting researchers and obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 19, 2020.
Original Filing: 301213704.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including annual appropriations for the National Institutes of Health and the National Science Foundation.
COVID related relief packages. including:
- HR 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
- HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act
Funding issues pertaining to commuter transportation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
Issues pertaining to COVID-19, including testing and animal model development.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations.
Issues pertaining to COVID-19 diagnosis and animal model discovery.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Issues pertaining to the transportation and shipment of laboratory animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in biomedical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to recruiting researchers and obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 10, 2020.
Original Filing: 301186733.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including:
- HR 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
- HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act
Funding issues pertaining to commuter transportation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
Issues pertaining to COVID-19, including testing and animal model development.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations.
Issues pertaining to COVID-19 diagnosis and animal model discovery.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Issues pertaining to the transportation and shipment of laboratory animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in biomedical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to recruiting researchers and obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 16, 2020.
Original Filing: 301168125.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including:
- HR 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.
- HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act
Funding issues pertaining to commuter transportation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
Issues pertaining to COVID-19.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations.
Issues pertaining to COVID-19 diagnosis and model discovery.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in biomedical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 17, 2020.
Original Filing: 301110208.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
The background and use of animal models in biomedical research.
National Institutes of Health and the Federal Bureau of Investigation scrutinizing researchers with global research collaborations.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in biomedical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 18, 2019.
Original Filing: 301070055.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
The background and use of animal models in biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism and the Animal Welfare Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in medical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Rural transportation needs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 18, 2019.
Original Filing: 301049611.xml
Lobbying Issues
Issues pertaining to funding for biomedical research, including HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
S.850 and HR 1873, the HOPE for Alzheimer's Disease Act.
S 901 and HR 1903, the Younger Onset Alzheimer's Disease Act.
Implementation of Public Law No: 115-406, the BOLD Infrastructure for Alzheimer's Act.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
HR 2740, the Fiscal Year 2020 Labor, Health and Human Services, and Education appropriations bill.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in medical research.
Issues pertaining to taxable transportation benefits for employees of 501(c)3 nonprofit institutions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to obtaining visas for foreign citizen employees of nonprofit research institutions.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 18, 2019.
Original Filing: 301028917.xml
Lobbying Issues
Issues pertaining to funding for biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to authorization and funding for disease research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to basic science research and biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues pertaining to animal rights activism.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues pertaining to animal rights activism, biomedical research, animals used in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the shipment of animals for use in medical research.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301016044.xml
Lobbying Issues
Issues pertaining to funding for the National Institutes of Health and National Science Foundation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to NIH funding and regulation
Issues relating to disease research
Opioid addiction
S. 2076, the BOLD Infrastructure for Alzheimer's Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Farm Bill, H.R. 2.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Regarding docket number DOT-OST-2018-0124 and other issues related to the transportation of animals used in biomedical research.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on Oct. 22, 2018.
Original Filing: 300994399.xml
Lobbying Issues
Issues pertaining to funding for the National Institutes of Health and National Science Foundation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to NIH funding and regulation
Issues relating to disease research
Opioid addiction
S. 2076, the BOLD Infrastructure for Alzheimer's Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Farm Bill, H.R. 2.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal use in biomedical research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Regarding docket number DOT-OST-2018-0124 and other issues related to the transportation of animals used in biomedical research.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on July 20, 2018.
Original Filing: 300977788.xml
Lobbying Issues
Issues pertaining to funding for the National Institutes of Health and National Science Foundation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to NIH funding and regulation
Issues relating to disease research
Opioid addiction
S. 2076, the BOLD Infrastructure for Alzheimer's Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Farm Bill, H.R. 2.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to animal use in biomedical research.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on April 20, 2018.
Original Filing: 300953041.xml
Lobbying Issues
Issues pertaining to funding for National Institutes of Health.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to NIH funding and regulation
Issues relating to disease research
Opioid addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Issues related to the Farm Bill, H.R. 2.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, THE JACKSON LABORATORY had in-house lobbyists. The report was filed on March 9, 2018.
Original Filing: 300941205.xml
Lobbying Issues
Issues pertaining to NIH funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to NIH funding and regulation
Issues relating to disease research
Opioid addiction
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to biomedical research.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2017
THE JACKSON LABORATORY filed a lobbying registration on Jan. 17, 2018 for in-house lobbying efforts, effective Oct. 2, 2017.
Original Filing: 300925821.xml
Issue(s) they said they’d lobby about: Appropriations for National Institutes of Health
Issues pertaining to disease research
Issues pertaining to biomedical research .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...